Darrell H Carney

This inventor holds 28 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Thrombin Peptide Derivatives. Top assignees: Orthologic Corp., The University of Texas System, Chrysalis Biotechnology. Active years: 1994-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darrell H Carney. Retrieved from https://idiyas.com/inventor/darrell-h-carney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 8)

% Patents Active = 67.9

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 157(Granted Patents)

Location History:

Galveston, TX (US) (1994 - 2011)
Dickinson, TX (US) (1996 - 2019)

Company Filing History:

The University of Texas System

patents

2 out of 2

Chrysalis Biotechnology

Texas A&M University System

patents

6. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2019

Loading Chart...

Areas of Expertise:

Thrombin Derivatives

Medulloblastoma Treatment

Dermal Ulcers

Endothelial Dysfunction

Bone Growth

Pharmaceutical Composition

Peptide Neutrophil Agents

Chronic Ulcers

Cartilage Growth

Therapeutic Methods

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10220078 - Methods of using thrombin derivatives to treat medulloblastoma (2019-03-05),

2. 8952129 - Method of treating degenerative diseases (2015-02-10),

3. 8334259 - Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative (2012-12-18),

4. 7935341 - Antibodies to complementary peptides of thrombin or portions thereof (2011-05-03),

5. 7919457 - Thrombin peptide derivative dimers (2011-04-05),

6. 7875588 - Methods of therapy using pharmaceutical composition for thrombin peptide derivatives (2011-01-25),

7. 7833982 - Methods of treating dermal ulcers with thrombin derived peptides (2010-11-16),

8. 7732411 - Methods of therapy with thrombin derived peptides (2010-06-08),

9. 7713934 - Thrombin peptide derivatives (2010-05-11),

10. 7456250 - Thrombin peptide derivative dimers (2008-11-25),

11. 7378500 - Use of thrombin-derived peptides for the therapy of chronic dermal ulcers (2008-05-27),

12. 7304035 - Stimulation of bone growth with thrombin peptide derivatives (2007-12-04),

13. 7291596 - Pharmaceutical composition for thrombin peptide derivatives (2007-11-06),

14. 7214661 - Methods of therapy with thrombin derived peptides (2007-05-08),

15. 7049294 - Use of thrombin-derived peptides for the therapy of chronic dermal ulcers (2006-05-23),

Title: Inventor Darrell H Carney - Revolutionizing Industries with Innovation

Introduction: Darrell H Carney, a visionary inventor hailing from Galveston, TX, has made significant contributions to the world of technology and beyond through his groundbreaking innovations.

Latest Patents: Darrell H Carney's latest patents include cutting-edge solutions in renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Darrell H Carney has established himself as a pioneer in the field of innovation. His work has not only garnered critical acclaim but has also brought tangible benefits to various industries.

Collaborations: Throughout his career, Darrell H Carney has collaborated with leading research institutions, top-tier universities, and innovative companies to bring his ideas to life. These collaborations have been instrumental in pushing the boundaries of what is possible.

Conclusion: In conclusion, Darrell H Carney's passion for innovation, coupled with his relentless drive to make a positive impact, sets him apart as a true trailblazer in the world of inventions. His work continues to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.